Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.
| Autor: | Giannakakou, Paraskevi, Poy, George, Zhan, Zhirong, Knutsen, Turid, Blagosklonny, Mikhail V, Fojo, Tito |
|---|---|
| Zdroj: | Oncogene. 6/22/2000, Vol. 19 Issue 27, p3078. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|